Pharmaceuticals and Drug Development

  1. Pharmaceuticals and Drug Development

First wireless map of worm’s nervous system revealed

This huge step forward in understanding how neurons communicate through extremely short proteins called neuropeptides will help scientists understand how our emotions and mental states are controlled, as well as widespread neuropsychiatric conditions like eating disorders, OCD and PSTD.   The map, which details 31,479 neuropeptide interactions between the worm’s 302 neurons, shows where each neuropeptide, […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Ixchiq (Chikungunya Vaccine, Live) for the Prevention of Disease Caused by Chikungunya Virus

FDA Approves Ixchiq (Chikungunya Vaccine, Live) for the Prevention of Disease Caused by Chikungunya Virus Saint-Herblain (France), November 10, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Administration (FDA) has approved Ixchiq®, Valneva’s single-dose, live-attenuated vaccine indicated for the prevention of disease […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

X4 Pharmaceuticals Announces FDA Acceptance with Priority Review of U.S. NDA for Mavorixafor in WHIM Syndrome

Treatment for: WHIM Syndrome X4 Pharmaceuticals Announces FDA Acceptance with Priority Review of U.S. NDA for Mavorixafor in WHIM Syndrome BOSTON, Oct. 31, 2023 (GLOBE NEWSWIRE) –X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that the United States Food and Drug […]
Written by
One-Day Induction of XR Buprenorphine Feasible for Fentanyl Use in OUD
  1. Pharmaceuticals and Drug Development

One-Day Induction of XR Buprenorphine Feasible for Fentanyl Use in OUD

Medically reviewed by Drugs.com. By Elana Gotkine HealthDay Reporter WEDNESDAY, Nov. 8, 2023 — For individuals with opioid use disorder (OUD) using fentanyl, a one-day induction of extended‐release buprenorphine is a feasible treatment approach, according to a study published online Nov. 8 in the American Journal on Addiction. John J. Mariani, M.D., from the New […]
Written by
  1. Pharmaceuticals and Drug Development

Cancer Research UK and the KWF Dutch Cancer Society enter partnership to bring multiple drugs into clinical development

Under the partnership, KWF intends to provide funding to enable the development of select early phase clinical programmes* through Cancer Research UK’s Centre for Drug Development (CDD). Cancer Research UK’s CDD will be utilising its 30 years of experience in ushering first-in-class and best-in-class therapeutics through the clinic to sponsor and manage KWF-supported trials as […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Zituvimet (sitagliptin and metformin hydrochloride) to Treat Adult Patients With Type 2 Diabetes Mellitus

FDA Approves Zituvimet (sitagliptin and metformin hydrochloride) to Treat Adult Patients With Type 2 Diabetes Mellitus November 06, 2023, Ahmedabad, India — Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) today announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for Zituvimet (Sitagliptin and Metformin hydrochloride) […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA

Generic name: apomorphineTreatment for: Hypomobility in Parkinson’s Disease Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA ROCKVILLE, Md., Nov. 02, 2023 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the […]
Written by
Women May Not Recognize Non-Lump Symptoms of Breast Cancer
  1. Pharmaceuticals and Drug Development

Women May Not Recognize Non-Lump Symptoms of Breast Cancer

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 3, 2023. By Lori Solomon HealthDay Reporter FRIDAY, Nov. 3, 2023 — Fewer than half of women recognize symptoms other than a lump in the breast as a potential sign of breast cancer, according to the results of a survey commissioned by The Ohio State […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

FDA Approves Voquezna (vonoprazan) for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in Adults

FDA Approves Voquezna (vonoprazan) for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in Adults FLORHAM PARK, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today the U.S. Food and Drug […]
Written by

Good Reads

Can Tariffs Lead to a More Circular Economy? – State of the Planet

As global trade tensions mount and countries recalibrate their economic priorities, tariffs may have the ability to play an unexpected role in the sustainability conversation. Tariffs on imports, while often viewed as controversial and protectionist weapons, could paradoxically drive the shift not only toward less production, but also toward more localized, circular and environmentally conscious […]
Written by
How AI is supercharging plant immunity to fight deadly bacteria

How AI is supercharging plant immunity to fight deadly bacteria

Scientists at the University of California, Davis, used artificial intelligence to help plants recognize a wider range of bacterial threats — which may lead to new ways to protect crops like tomatoes and potatoes from devastating diseases. The study was published in Nature Plants. Plants, like animals, have immune systems. Part of their defense toolkit […]
Written by

Worlwide

Can Tariffs Lead to a More Circular Economy? – State of the Planet

As global trade tensions mount and countries recalibrate their economic priorities, tariffs may have the ability to play an unexpected role in the sustainability conversation. Tariffs on imports, while often viewed as controversial and protectionist weapons, could paradoxically drive the shift not only toward less production, but also toward more localized, circular and environmentally conscious […]
Written by
How AI is supercharging plant immunity to fight deadly bacteria

How AI is supercharging plant immunity to fight deadly bacteria

Scientists at the University of California, Davis, used artificial intelligence to help plants recognize a wider range of bacterial threats — which may lead to new ways to protect crops like tomatoes and potatoes from devastating diseases. The study was published in Nature Plants. Plants, like animals, have immune systems. Part of their defense toolkit […]
Written by
Koalas on the brink: Precision DNA test offers a lifeline to Australia’s icons

Koalas on the brink: Precision DNA test offers a lifeline to Australia’s icons

A University of Queensland-led project has developed a tool to standardize genetic testing of koala populations, providing a significant boost to conservation and recovery efforts. Dr Lyndal Hulse from UQ’s School of the Environment said the standardized koala genetic marker panel provides a consistent method for researchers nationwide to capture and share koala genetic variation, […]
Written by

Trending

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.